Candriam SCA’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Buy |
|
|||||
|
2025
Q1 | $7.08M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.81M | Sell |
|
|||||
|
2023
Q4 | $6.25M | Sell |
|
|||||
|
2023
Q3 | $4.24M | Hold |
|
|||||
|
2023
Q2 | $6.7M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.39M | Hold |
|
|||||
|
2020
Q4 | $3.53M | Sell |
|
|||||
|
2020
Q3 | $11.2M | Sell |
|
|||||
|
2020
Q2 | $11.6M | Buy |
|
|||||
|
2020
Q1 | $3.65M | Hold |
|
|||||
|
2019
Q4 | $3.73M | Sell |
|
|||||
|
2019
Q3 | $3.57M | Hold |
|
|||||
|
2019
Q2 | $4.33M | Hold |
|
|||||
|
2019
Q1 | $5.19M | Buy |
|
|||||
|
2018
Q4 | $3.54M | Buy |
|
|||||
|
2018
Q3 | $2.99M | Buy |
|
|||||
|
2018
Q2 | $2.63M | Buy |
|